
Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: Granulomatosis with poliangeitis, previously known as Wegener’s granulomatosis, is a multisystemic disease characterized by necrosis in the upper or lower portions of the respiratory system, glomerulonephritis and necrotizing vasculitis. Though a rare disease, its presentation is acute and rapidly progressive. The radiological pattern includes parenchymal alteration in 50% of the patients, with lung consolidation seen on the CT SCAN or ground glass opacities secondary to diffuse pulmonary hemorrhage, usually bilateral. Currently, the median survival time with treatment is longer than 20 years. Case: This is the case of a female patient younger than 40 years-old who had a cavitated mass in her lungs. She was transferred from another hospital after receiving several antibiotic schemes without improving her clinical condition. She also received antituberculous treatment. At CAM Hospital, the diagnosis was made on the ground of histopatologic reports and immunologic tests. Corticoisteroids and inmunosupressive treatment improved definitively her clinical and radiologic picture. Discussion: Granulomatosis with Poliangiitis is a necrotizing inflammation involving the respiratory tract, lungs and kidneys. It is defined by the presence of ANCA PR3 positive antibodies in most patients. Its evolution varies and often tends to be chronic. It is treated with corticosteroids and immunosuppressors. After remission, the probability of recurrence goes from 50 to 70%. This could be be prevented with adequate follow-up and maintenance treatment.
Falk Ronald, Merkel Peter, King Talmudge. Clinical manifestations and diagnosis of granulomatosis with polyangitis and microscopic polyangitis. Post TW, ed. Uptodate. MA: UptoDate Inc. http://www.
uptodate.com ( accessed on September 2017 )
Glassock Richard, Flanerty Kevin, King Talmedge; Respiratory tract involvement in granulomatosis
with polyangitis and microscopic polyangitis, Post TW, ed. Uptodate. MA: UptoDate Inc. http://www.uptodate.com ( accessed on September 2017 ) 3. Trenor L, Martínez C, Pallardó C. Vasculitis sistémicas asociadas a ANCA: Granulomatosis de Wegener y Poliangeítis Microscópica. Sección de Reumatología, Hospital de la Ribera, Valencia
Duna, GF, Cotch, MF, Galperin C. et al. Wegener’s granulomatosis: Role of environmental exposures. ClinExpRheumatol 1998; 16:669-74
Vera O, Olvera A, McDonald A, Pacheco M y Gayosso J. Granulomatosis de Wegener, abordaje diagnóstico y terapéutico. Departamento de Medicina Interna del Hospital de Especialidades y Hospital de Infectología, Centro Médico Nacional La Raza, IMSS, México DF, 2012
Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol. 2009 Jun; 123(6):1226-36
Flores-Suárez LF. Antineutrophil cytoplasm autoantibodies: usefulness in rheumatology. Reumatol Clin. 2012 Nov-Dec;8(6):351-7
Homeister JW, Jennette JC, Falk RJ. Immunologic mechanisms of vasculitis. In: Alpern RJ, Moe OW,
Caplan M (eds). Seldin and Giebisch’s The Kidney. Amsterdam: Ed. Elsevier; 2013. pp. 2817-46
GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. Arch Pathol 1954; 58:533-553
Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment.
Autoimmun Rev. 2014 Nov; 13(11):1121- 5
Landman S, Burgener F. Rochester. Pulmonary manifestations in Wegener´s granulomatosis. AJR Am J Roentgenol 1974; 122:750-57
Aberle DR, Gmsu G, Lynch D. Thoracic manifestations of Wegener granulomatosis: diagnosis and course. Radiology 1990; 174:703-09
Mayberry JP, Primack SL, Müller NL. Thoracic manifestations of systemic autoimmune diseases: radiographic and high resolution CT findings. Radiographics 2000;20:1623–35
Bacon PA. The Spectrum of Wegener’s Granulomatosis and Disease Relapse. N Eng J Med. 2005; 352:330-2
Specks U, Deremee RA. Granulomatous Vasculitis Wegener’s. Granulomatosis and Churg-Strauss síndrome. Rheum Dis Clin North Am. 1990; 16: 377-97
Brunton Lawrence, Chabner Bruce, Knollman Bjorn (2012). Godman y Gilman: Las bases farmacológicas de la terapéutica. Editorial McGrawhill. México. 12va edición. Sección VII.
Capítulo 42
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.